Ace:
News

Research

Ace Alzheimer Center Barcelona presents 5 scientific posters at the AAIC 2021

27/07/2021
With this new and broad participation in the AAIC, one of the most important forums in the field of dementias, Ace Alzheimer Center Barcelona is positioned as a model entity in our country in the field of the research of Alzheimer's and other dementias.

An Ace study demonstrates the efficacy of teleneuropsychology in diagnosis

06/07/2021Diagnosis
The variables studied were the structure of the test, the degree of interpretation of the data and its ability to detect cognitive impairment.

The first edition of the Global Research Summit closes with successful attendance

01/07/2021Research
More than 300 professionals in the field of dementia from 18 nationalities have participated in the three sessions of the Ace Global Research Summit 2021.

The United States approves the use of Aducanumab: a treatment for Alzheimer's disease

11/06/2021Day care and treatment
Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.

Fundació Mir-Puig, collaborator of Ace Alzheimer Center Barcelona

10/06/2021SCR
The charity based in Barcelona signs a collaboration agreement to offer financial support to the research projects that Ace develops.

The webinar “Molecular Biomarkers of Neurodegeneration” stands out for the high participation of attendees

01/06/2021News
More than 165 attendees of 18 different nationalities gathered to hear the latest news on molecular biomarkers in neurodegenerative diseases